Immunai Decoding Immunity for Next-Generation Therapeutics

Contact for Pricing

What is Immunai?

Immunai is a biotechnology company focused on decoding the complexities of the immune system. The company leverages advanced technologies to map the immune system at an unprecedented scale and resolution, aiming to improve the development of immune-related therapeutics.

Immunai's platform supports critical decision-making throughout the drug discovery and development process. By integrating multiomic data generation, a vast immune-focused database (AMICA), and machine learning, Immunai provides actionable recommendations to accelerate the delivery of better therapies to patients.

Features

Target Discovery: Identify novel high impact targets linked to disease
Preclinical Evaluation: Prioritize the most promising drug candidates for development
Clinical Trial Optimization: Better understand drug mechanism of action, identify the right groups of patients and the best treatment strategies to maximize trial success
AMICA: The world’s largest immune-focused, harmonized single-cell database
Multiomic Data Generation: High-quality multiomic data from clinical and preclinical samples
Machine Learning Platform: Computes novel immune features, linking immune mechanisms to treatment responses and outcomes
Functional Genomics Validation: Validates ML-driven hypotheses in the lab